| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Cue Biopharma, Inc.'s insiders have reduced their positions by a net 86,790 shares worth roughly $2.4M. In the past 30 days, 0 insiders bought and 3 sold.
All 3 insiders who sold still hold shares after their sales. Classified under Biotechnology (Health Care sector), CUE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 694.9K | $19.49M | -11,087 | |
| Other | 116.7K | $3.27M | -1,844 | |
| VP | 47.8K | $1.34M | -1,144 | |
| Dir | 32.6K | - | - | |
| Other | 31.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2023 | Kiener Peter A72 | Director | Sale+OE | 9,325 | $3.28 | $30,586.00 | -96.3% | +16.1% | -42.4% | |
| May 27, 2022 | Morich Frank | Director | Buy | 28,000 | $3.75 | $105,000.00 | New | -23.3% | +1.3% | |
| May 24, 2022 | Fletcher Aaron G.L.47 | Director | Buy | 205,000 | $3.47 | $711,700.00 | +27.9% | -8.4% | +16.5% | |
| Mar 31, 2022 | Fletcher Aaron G.L.47 | Director | Buy | 735,000 | $4.76 | $3,498,600.00 | New | -41.8% | -26.8% | |
| Nov 16, 2021 | Kiener Peter A72 | Director | Sale+OE | 20,176 | $17.93 | $361,690.02 | - | -60.7% | -78.4% | |
| Nov 15, 2021 | Suri Anish69 | President and CSO | Sale+OE | 8,000 | $18.05 | $144,400.00 | -7.8% | -62.5% | -78.8% | |
| Nov 11, 2021 | Suri Anish69 | President and CSO | Sale+OE | 20,000 | $15.07 | $301,354.00 | -17.5% | -54.2% | -79.2% | |
| Oct 1, 2021 | Millar Kerri-Ann | Chief Financial Officer | Sale+OE | 1,251 | $14.21 | $17,782.84 | -10.7% | -22.0% | -84.7% | |
| Sep 24, 2021 | Passeri Daniel R | Chief Executive Officer | Buy | 3,400 | $14.72 | $50,051.40 | +6.5% | -14.2% | -81.7% | |
| Sep 23, 2021 | Suri Anish69 | President and CSO | Sale+OE | 20,000 | $15.23 | $304,646.00 | -21.1% | -21.4% | -82.2% |